Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q1 2022 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2022-05-12

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 12, 2022

Total Value: $369M (100.0% shares, 0.0% debt)

Holdings (7)

CNTA CENTESSA PHARMACEUTICALS PLC 48.5%

Value $179M Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 18.1%

Value $66.88M Shares 3,039,892 Est. Cost $17.87 Unrealized +6.6%

PCVX VAXCYTE INC 12.3%

Value $45.58M Shares 1,887,478 Est. Cost $32.16 Unrealized -32.1%

— MERUS N V 11.5%

Value $42.3M Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 7.6%

Value $28.14M Shares 2,067,861 Est. Cost $25.13 Unrealized -35.7%

— CHECKMATE PHARMACEUTICALS IN 1.3%

Value $4.79M Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 0.6%

Value $2.371M Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$179M	48.5%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$66.88M	18.1%	$17.87	+6.6%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$45.58M	12.3%	$32.16	-32.1%	COM	92243G108
—	MERUS N V	1,600,000	$42.3M	11.5%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$28.14M	7.6%	$25.13	-35.7%	COM	71722W107
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$4.79M	1.3%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$2.371M	0.6%	$3.82	—	COM	H5861P103